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Abstract
Middle cerebral artery occlusion in rodents remains a widely used model of ischemic stroke. Recently, we reported the
occurrence of retinal ischemia in animals subjected to middle cerebral artery occlusion, owing in part to the circulatory
juxtaposition of the ophthalmic artery to the middle cerebral artery. In this study, we examined the eye hemodynamics and
visual deficits in middle cerebral artery occlusion-induced stroke rats. The brain and eye were evaluated by laser Doppler at
baseline (prior to middle cerebral artery occlusion), during and after middle cerebral artery occlusion. Retinal functionrelevant behavioral and histological outcomes were performed at 3 and 14 days post-middle cerebral artery occlusion.
Laser Doppler revealed a typical reduction of at least 80% in the ipsilateral frontoparietal cortical area of the brain during
middle cerebral artery occlusion compared to baseline, which returned to near-baseline levels during reperfusion. Retinal
perfusion defects closely paralleled the timing of cerebral blood flow alterations in the acute stages of middle cerebral artery
occlusion in adult rats, characterized by a significant blood flow defect in the ipsilateral eye with at least 90% reduction during
middle cerebral artery occlusion compared to baseline, which was restored to near-baseline levels during reperfusion.
Moreover, retinal ganglion cell density and optic nerve depth were significantly decreased in the ipsilateral eye. In addition, the
stroke rats displayed eye closure. Behavioral performance in a light stimulus-mediated avoidance test was significantly
impaired in middle cerebral artery occlusion rats compared to control animals. In view of visual deficits in stroke patients,
closely monitoring of brain and retinal perfusion via laser Doppler measurements and examination of visual impairments may
facilitate the diagnosis and the treatment of stroke, including retinal ischemia.
Keywords
stroke, retinal ganglion cell, optic nerve, animal model, laser doppler

Introduction
Stroke is ranked fourth among causes of death and is
the leading cause of long-term disability in the United
States1–3. Ischemic strokes comprise 87% of all strokes. In
2011, the direct and indirect total cost of stroke was 33.6
billion dollars and is projected to triple from 71.6 billion to
148.1 billion dollars between 2012 and 20303,4. Ischemic
stroke refers to a restriction of blood supply to a region or
regions of the brain. As the blood supply is disrupted, oxygen and nutrition are not delivered to meet the metabolic
demands, resulting in the development of an infarct area5.
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Retinal ischemia is a condition that occurs when blood is cut
off from the retina, causing those cells to die. Because the
retina is an extension of the central nervous system, physiological response to retinal ischemia is very similar to
ischemic stroke6.
Middle cerebral artery occlusion (MCAO) in rodents is
widely used as a model for ischemic stroke7–11. A filament is
advanced through the internal carotid artery (ICA), blocking
the base of the MCA12,13. Due to the proximity of the
ophthalmic artery to the MCA, MCAO blocks both arteries,
causing cerebral and retinal ischemia14,15. Previous reports
have touched on retinal deficits arising from MCAO in
rodents, which accompany neurostructural and neurological
deficits14,15. The reported retinal dysfunctions include electroretinogram alterations16–18, retinal cell loss14,15, and retinal gliosis18. It has been proposed that a reduction in ocular
blood flow, leading to ischemia-induced direct necrotic retinal cell death, and metabolic stress, resulting in apoptotic
retinal cell death, are the degenerative pathways leading to
these effects14,15. Clinically, ocular ischemia can occur in
conjunction with cerebral stroke19 and, due to the retina’s
high metabolic demand, any hindrance in the retina’s blood
supply can easily lead to a reduced supply of oxygen, resulting in retinal ischemia6,20. Because retinal ischemia is a
primary cause of blindness6,20, and with stroke a major cause
of death and disability21,22, a better understanding of the
underlying pathologies may help in developing novel treatment strategies. In this study, we evaluated the retinal hemodynamic effects of MCAO in rats, by using laser Doppler in
concert with immunohistochemical and structural analysis of
the optic nerve to further reveal the overlapping pathological
deficits between retinal ischemia and MCAO.

Materials and methods
Subjects
All experiments were conducted in accordance with the
National Institute of Health Guide and Use of Laboratory
Animals, and were approved by the Institutional Animal
Care and Use committee of the University of South Florida,
Morsani College of Medicine, USA. Rats were housed two
per cage in a temperature- and humidity-controlled room that
was maintained on 12/12 hour-light/dark cycles. They had
free access to food and water. All procedures were performed by personnel blinded to the treatment condition.

Surgical procedures
Adult Sprague-Dawley rats (n ¼ 24) were subjected to stroke
(n ¼ 16) or sham surgery (n ¼ 8) anesthetized by a mixture
of 1–2% isoflurane in nitrous oxide/oxygen (69%/30%) via
face mask. Body temperature was maintained at 37 + 0.3 C
during the surgical procedures. The midline skin incision
was made in the neck with subsequent exploration of
the right common carotid artery (CCA), the external carotid
artery, and ICA. A 4-0 monofilament nylon suture (27.0–
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28.0 mm) was advanced from the CCA bifurcation until it
blocked the origin of the MCA. Animals were allowed to
recover from anesthesia during MCAO. After 60 min of
transient MCAO, animals were re-anesthetized with 1–2%
isoflurane in nitrous oxide/oxygen (69%/30%) using a face
mask and re-perfused by withdrawal of the nylon thread. Animals receiving the sham operation were anesthetized with 1–
2% isoflurane in nitrous oxide/oxygen (69%/30%) via face
mask. A midline incision was made in the neck and the right
CCA was isolated, but without insertion of the monofilament
into the CCA. The animals were then closed and allowed to
recover from anesthesia. Brain and eye blood flow recordings
were obtained using a laser Doppler (Perimed, Periflux System 5000, Las Vegas, NV, USA). For baseline brain, the laser
Doppler probe was placed over the right frontoparietal cortical
area supplied by the MCA. For baseline eye, the laser Doppler
probe placed over the retina of the right eye. During MCAO,
the brain decrease was reported as relative unit values, which
were obtained by a laser Doppler probe placed again over the
right frontoparietal cortical area. Similarly, during MCAO,
the eye decrease was reported as relative unit values, which
were obtained by a laser Doppler probe placed again over the
retina of the right eye. The procedure mentioned above was
repeated to generate the “after reperfusion MCAO” laser Doppler readings. During the operations, the body temperature
was kept at 37 C with a feedback-controlled heating pad.
Physiological outcome parameters of MCAO were kept constant across all animals throughout the experiment.

Measurement of infarct volumes
Rats were euthanized with CO2 overdose and perfused with
saline at 3 days (n ¼ 9; sham ¼ 4) and 14 days (n ¼ 7;
sham ¼ 4) after MCAO for 2, 3, 5-triphenyltetrazolium
chloride staining (TTC). The brains were quickly removed;
seven coronal sections (one in the middle, two towards the
back, and four towards the front) of 2-mm thickness were
prepared23. The brain slices were incubated in a 2% solution
of 2,3,5-triphenyltetrazolium chloride (Sigma Aldrich, St.
Louis, MO, USA) with phosphate-buffered saline (PBS) at
37 C for 7 min in the dark and fixed in 4% buffered formaldehyde solution. The areas with normal cellular respiration stained dark red, while the infarct area remained
unstained due to lack of cellular respiration. Brain slices
were scanned, and infarct areas were measured using an
imaging analysis software (Image J; National Institute of
Health, Bethesda, MD). The infarct volumes were calculated
with an edema correction.

Enucleation and immunohistochemistry in the retina
The eyes were enucleated after a reference point was taken
to label the superior pole and were immediately immersed in
cold PBS (pH 7.4). The anterior segments of the eyes were
removed and the retinas were isolated from the eyecup and
post-fixed for 1 h in 4% glutaraldehyde in PBS. After being
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rinsed 3 x 10 min in PBS, retina tissues were processed as
whole mounts. A monoclonal antibody against NeuN was
obtained from Abcam (1:250; Cambridge, MA). It was
processed free-floating in small vials with gentle agitation.
Standard immunocytochemical techniques and immunocytochemical methods that have been described in detail in previous papers were used. For detection by immunofluorescence,
the secondary antibodies were fluorescein conjugated antimouse IgG (1:500, Vector Lab., Burlingame, CA, USA).
Immunofluorescence images were obtained on a Zeiss fluorescence microscope. As a control, some tissues were incubated
in the same solution without the addition of the primary antibody. These control tissues showed no NeuN immunoreactivity. Retina sections were measured using an imaging analysis
software (Image J; National Institute of Health, Bethesda, MD,
USA). To compare the number of NeuN cells in the normal
retina, and the ipsilateral and contralateral sides, we also
counted labeled cells in five sequential fields, each 500 mm x
500 mm in area. Three tissue sections from each group (sham,
contralateral, and ipsilateral) were measured.

Measurement of the optic nerve
The optic nerves were collected at the same time point
described above for structural analysis. The anterior segments of the eyes were removed and the optic nerve was
isolated from the brain and post-fixed for 1 h in 4% glutaraldehyde in PBS. The optic nerves were stored in PBS until
the time of analysis. Optic nerve images were obtained on an
Olympus microscope. Optic nerve depths were measured
using a microscope software. To determine the distributional
types of optic nerve, we sampled fields from each group
(three animals), each 500 mm x 500 mm in area. Analysis
was done with a 40X Zeiss Plan-Apochromat objective.

Eye score evaluation
After stroke, a behavioral evaluation for the eye tests was
performed. The rats were evaluated for severity of stroke
based on eye closure. The animals displayed a narrowing
of the orbital area, a tightly closed eyelid, or an eye squeeze.
An eye squeeze is defined as the contraction of the orbital
muscles around the eye. A wrinkle may be visible around the
eye. As a guideline, any eye closure that reduces the eye size
by more than half was coded as “2”. We note that sleeping
rats display closed eyes, and this may be mistaken for a
tightly closed eyelid. Photographs of sleeping rats should
therefore not be taken and/or coded. For each trial, animals
received a score of 0, 1, 2, or 3 (0: normal; complete eye
open, 1: mild; eye slightly closed, 2: moderate; eye is half
closed 3: severe; complete eye closure).

Avoidance task
This behavioral test followed our previous publications with
modifications7,24. The training apparatus was a 50.5  16 
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27 cm box comprising a dark compartment made of black
Plexiglass and a white compartment made of white Plexiglass. The ceiling of both compartments was transparent to
allow observation of the animal’s activity. Both compartments had metal grid floors to which a continuous electric
footshock (DC, 2 mA) could be delivered. Luminance at the
white compartment of the box was 12.6 lux. Continuous
white noise (70 dB) was broadcast through a speaker in the
test room throughout the experimental session.
Each animal was placed individually in the box for 6 min
habituation, during which it could freely explore the box.
After the habituation period, the animal was placed in the
dark compartment and the electric shock paired with white
light (200 lux25) was immediately switched on in this compartment. This training continued until the subject stayed in
the safe (i.e. white) compartment for 3 min. The retention
test was undertaken on the following day. No electric shock
was given, but the white light was switched on. The retention
test started by placing the animal in the safe white compartment. If the rat entered the dark compartment within less
than 3 min, the conditioning procedure described above was
repeated. This training procedure continued until the animal
stayed in the white compartment for 3 min. Following acquisition of the avoidance task, all subjects underwent the
MCAO stroke or sham surgery (see separate Methods section on Surgical procedures). Thereafter, stroke and sham
animals underwent shock/light recall tests at day 3 and day
14. Initially, animals were placed in the dark compartment,
then shock was introduced, and the amount of time it took
the animal to move to the white safe compartment was
recorded. At 1 h after the shock recall test, the light recall
test was conducted by placing the animal in the dark compartment, then introducing the white light, and the amount of
time it took the animal to move to the white safe compartment was recorded. The subjects were removed from the box
once they entered the white compartment.

Statistical analysis
Data are presented as the mean + SEM and analyzed using
Sigma plot 8.0 program. Statview software was used to run
analysis of variance followed by posthoc Bonferroni test.
Statistical significance was preset at p < 0.05 (GraphPad
version 5.01). The Kolmogorov-Smirnov test was performed
to assess normality and the resulting values were less than
5% of the critical values.

Results
MCAO produces cerebral infarcts
As routinely reported, the 60-min MCAO stroke produced
consistent cortical and striatal infarcts within the ipsilateral
hemisphere as revealed by TTC staining (Figure 1). The
infarct size average was 19.8% at 3 days, and 21.21% at
14 days after stroke compared to sham animals (p < 0.05).
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Figure 1. Middle cerebral artery occlusion (MCAO) produces typical cerebral infarcts. Tissue sections were processed with (2,3,5triphenyltetrazolium chloride (TTC)) to reveal cerebral infarcts. (A) TTC-stained brain in sham and MCAO at 3 days and 14 days after
stroke. The white color represents the infarct area. (B) Quantification of infarcts (percentage of impact area + SEM) reveals visible infarcts
at 3 days and 14 days after stroke.

Figure 2. Middle cerebral artery occlusion (MCAO) alters retina cell survival and optic nerve depth. Representative images of NeuN
immunohistochemistry in retina to reveal retinal ganglion cell density (A; scale bar ¼ 25 um) and optic nerve depth (B; red line), which were
subsequently quantified and analyzed (C). The depth of the optic nerve and the density of retinal ganglion cells in MCAO rats showed a
general reduction compared to sham at 3 days and 14 days after stroke. Significance: *p < 0.05; **p < 0.01; ***p < 0.001.

MCAO induces ganglion cell death in the retina
There was a reduction of 57.66% (p < 0.05) in ganglion cell
density in the ipsilateral retina of the MCAO animals compared to sham animals at 3 days after stroke (Figures 2(a)
and (c)). This reduction exacerbated further to 68.21%
(p ¼ 0.000004) at 14 days after stroke. On the contralateral

side, the ganglion cell density decreased to 13.55% (p ¼ 0.27)
and 20.41% (p ¼ 0.009) compared to sham animals at 3 and
14 days after surgery, respectively. The differences between
the contralateral side and the ipsilateral side in ganglion cell
density were 44.11% (p ¼ 0.015) and 47.91% (p ¼ 0.0014) at
3 and 14 days post-surgery, respectively.
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Figure 3. Middle cerebral artery occlusion (MCAO) reduces blood flow in the brain and the eye and induces visual impairments. The laser
Doppler readings in both brain (A) and eye (B) displayed a similar pattern, characterized by significant blood flow reduction during MCAO,
then recovery towards baseline levels after reperfusion. Evaluation of ipsilateral eye closure revealed that stroke animals displayed a higher
score (i.e. a half-closed eye) compared to sham group with only very slight or no detectable eye closure (C). Moreover, the stroke animals
exhibited visual impairments as revealed in an avoidance test (D). Prior to stroke surgery, both groups of animals learned the avoidance task
by successfully preferring the safe place when the electric shock or the light stimulus was presented. After the stroke surgery, the MCAO
animals continued to prefer the safe place to avoid the electric shock, but they failed this task when presented only with the light stimulus
compared to sham animals, at 3 and 14 days post-surgery. Significance: *p < 0.05.

MCAO decreases optic nerve length (depth)
In general, there was a significant reduction in the depth of
the ipsilateral optic nerve compared to sham group (Figures
2(b) and (c)). At 3 days after MCAO, the depth of the ipsilateral and contralateral optic nerves decreased by 8.62% (p
¼ 0.23) and 18.56% (p ¼ 0.12), respectively, compared to
sham (p < 0.05). When the ipsilateral optic nerve was compared to the contralateral optic nerve, there was a 9.93%
reduction that almost reached significance (p ¼ 0.054). At
14 days after MCAO, the depths of optic nerves decreased by
3.69% in the contralateral (p ¼ 0.42), whereas it was significantly reduced by 14.5% in the ipsilateral (p ¼ 0.01) compared to sham groups. Another trend of reduction by 10.8%

(p ¼ 0.075) was detected in the ipsilateral optic nerve depth
when compared to the contralateral side.

MCAO reduces blood flow to both the brain
and the eye
Laser Doppler readings at baseline, during the MCAO stroke
surgery, and 3 and 14 days after stroke revealed altered
blood flow in both the brain and the eye (Figures 3(a) and
3(b)). Baseline laser Doppler blood flow perfusion units of
brain and eye were 315 + 19 and 610 + 18, respectively.
During MCAO, there were significant reductions in blood
flow to both the brain and the eye. The average of laser
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Doppler readings for the brain and the eye were 44.48 +
16.73 and 49.77 + 27.21, which equated to about 80%
and 89% reductions respectively, compared to baseline
readings in stroke animals. The laser Doppler readings
increased after reperfusion and trended towards near baseline levels by 14 days after stroke (**p < 0.01; ***p < 0.001;
****p < 0.0001).

Eye score test
After stroke, the animals were evaluated for severity of
stroke based on eye closure. Stroke animals showed a significantly higher score of eye closure compared to sham
group (Figure 3(c)). The average score for stroke animals
was around 1.1 thus indicating a half-closed eye compared to
around 0.4, indicating no detectable to very mild eye closure
in sham animals (p < 0.05).

Avoidance test
Before and after surgery, the animals were subjected to the
avoidance test (Figure 3(d)). Prior to stroke and sham surgeries, both groups of animals learned the avoidance task by
successfully preferring the safe place when the electric shock
was introduced or when presented with the light stimulus
alone that was previously associated with the electric shock.
Within 5 seconds of electric shock or light stimulus introduction, the animals moved to the safe compartment. However, following the stroke surgery, although the MCAO
animals continued to prefer the safe place to avoid the electric shock, they were not able to retain such tasks when
presented with the light stimulus compared to sham animals,
at 3 and 14 days post-surgery. Collectively, these results
indicated that although memory retention of the safe place
was intact (albeit in the presence of electric shock), the
animals were not able to process the “light stimulus” visual
cue, likely due to retinal damage associated with stroke
(p < 0.05).

Discussion
This study reports that filament MCAO model results in
retinal ischemia, causing damage to the retinal ganglion cell
and the optic nerve14,15,18. A similar pattern of alterations in
blood flow were detected both the brain and the eye prior to
stroke, during MCAO, and at 3 days and 14 days after stroke.
The histopathological and haemodynamics profile of
MCAO-induced retinal ischemia produced functional correlates as evidenced by visual impairments in a simple cognitive task. That retinal ischemia is demonstrated here to
closely accompany the MCAO stroke model replicates the
clinical setting with equally high incidence of visual impairments in ischemic stroke patients. The observation of retinal
ischemia with unfavorable haemodynamics, histopathological, and behavioral manifestations warrants its recognition as
a major pathological consequence of stroke.
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The occurrence of retinal ischemia after MCAO-induced
ischemic stroke is likely due to the proximity of the ophthalmic artery to the MCA, in that occlusion of the MCA is
almost certain to block blood supply to the ophthalmic
artery. Moreover, the retina is heavily vascularized and thus
highly susceptible to vascular metabolic stress. Laser Doppler readings in the retina closely paralleled the brain cerebral blood flow perfusion, characterized by significant
reduction in blood flow during MCAO, which reverted to
baseline after reperfusion. Our study showed the retinal damage worsened at 14 days after MCAO, extending the alterations seen in the acute phase from previous reports14,15,26.
The MCAO-induced retinal ischemia may trigger a cascade of cell death events, most mitochondrial dysfunctions,
as we recently reported27. At the functional level, stroke
animals displayed eye closure that may affect their perception and learning of visual cues. Indeed, stroke animals were
significantly impaired in their performance of the passive
avoidance task when light stimulus was used to alert an
impending aversive condition. Some functional deficits have
been reported with the retinal ischemia induced by MCAO,
such as electroretinogram alterations 16–18 , retinal cell
loss14,15, and retinal gliosis18.
A simple observation but with far-ranging application of
laser Doppler that we discovered here is its extended use for
detecting blood flow in eye. We showed here that the laser
Doppler is a sensitive tool in monitoring blood flow, thus it
stands as a reliable alternative method to its current use for
intra-cranial regional cerebral blood flow recording for measuring the haemodynamics of MCAO. Laser Doppler reading in the eye is less invasive and does not require additional
invasive procedures to the head, thereby circumventing
trauma to the already injured stroke brain. Accordingly, we
advance the novel use of laser Doppler of the eye as an
approach to reduce the chance of trauma and infection to
the head, allowing a minimally invasive approach to
the detection of altered blood flow after stroke. We
envision a rapid assessment of the severity of stroke using
a human-compatible laser Doppler in the emergency
medicine settings that would facilitate early initiation of
treatment intervention, such as tissue plasminogen activator
(tPA), which is limited to 4.5 hours after stroke onset.
Although further studies are required to fully reveal the
direct correlation between the pathological deficits arising
from retinal ischemia and the neurobehavioral outcomes7,
the current finding raises an important question about some
commonly used behavioral tests that rely on visual cues on
MCAO subjects28. The change in behavioral outcomes
observed in those tests might be due to the visual impairments, the stroke brain, or a combination of both. If the
results are caused by a visual impairment and not a brain
deficit, they can undermine the validity of the tests. For
example, the Morris Water Maze, a commonly used cognitive test, requires animals to use visual cues in conjunction
with memory to find the hidden platform. The poor performance of the animals might be due to the inability to
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visualize the environmental cues to navigate to the platform,
and not necessarily a cause-and-effect outcome of the stroke
brain. Hence, the result of the test might not indicate the
direct correlation between brain damage and functional deficit. Proper design of memory and learning paradigms that
incorporate visual perception may allow delineation of true
cognitive deficits from visual impairments. In the present
study, we were able to detect that memory retention of the
passive avoidance was intact, yet the visual perception of
light stimulus was impaired in stroke animals.
Visual impairments after stroke have been reported in
clinical settings29–31. Approximately 30% of stroke patients
experience some visual impairments31. Hence, we suggest
that stroke patients should also be screened for retinal damage as part of the disease differential diagnosis and its treatment regimen to improve the overall clinical outcome.
Clinical outcomes from transplantation of stem cells in
stroke, although mostly focused on repairing the brain32–40,
may benefit from exploring the grafted cells deposition and
function in the eye41,42.
In conclusion, the present study characterized the functional correlates of retinal ischemia in the MCAO rat model,
in particular demonstrating the changes in haemodynamics
in the eye that closely resembled the cerebral blood flow
alterations as measured by laser Doppler. Histopathological
deficits, as evidenced by retinal ganglion cell and optic nerve
damage, and visual impairments, as revealed by failure to
recognize light stimulus-cued avoidance test, accompanied
the MCAO-induced retinal ischemia. A better understanding
of stroke and retinal ischemia pathophysiology can help to
further understand the disease and to improve the current
standard treatment of care for stroke patients. To this end,
enhancing the retinal ganglion cell survival, such as by stemcell transplantation to repair mitochondrial dysfunction27,
may prove to be of therapeutic value to stroke and retinal
ischemia.
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